(lp0
S"Tetraphase Pharmaceuticals Inc Is Climbing Again Today -- Here's Why Motley Fool - Mar 10, 2017 Shares of Tetraphase Pharmaceuticals Inc , a clinical-stage biotech developing antibiotics, continued its impressive climb with another gain of about 15.8%, as of 11:46 a.m."
p1
aS"Tetraphase Pharmaceuticals, Ionis Pharmaceuticals, Facebook Stocks Moving Today Schaeffers Research  - Mar 10, 2017 The S&amp;P is set to snap a six-week winning streak, with traders turning their attention to next week's Fed decision after a blowout jobs report."
p2
aS'Zacks: Brokerages Anticipate Tetraphase Pharmaceuticals Inc  Will Post ... The Cerbat Gem - Apr 15, 2017 Tetraphase Pharmaceuticals logo Wall Street brokerages predict that Tetraphase Pharmaceuticals Inc  will announce sales of $1.69 million for the current quarter, Zacks Investment Research reports.Zacks: Brokerages Expect Tetraphase Pharmaceuticals Inc  to Post -$0.61 EPS - Markets Daily'
p3
aS"Tetraphase Pharmaceuticals'  CEO Guy Macdonald on Q4 2016 Results ... Seeking Alpha - Mar 9, 2017 Throughout 2016, the Tetraphase team successfully executed on our milestones and achieved important advances in each of our antibiotic development programs particularly with the advancement of eravacycline, our Phase 3 novel antibiotic candidate&nbsp;..."
p4
aS'Tetraphase Pharmaceuticals Inc.  Breaks into New 52-Week High on March ... Equities.com - Mar 31, 2017 Shares of Tetraphase Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $9.93. Shares closed at $9.19 after opening at $9.00 for a move of 3.84%.'
p5
aS'Tetraphase Pharmaceuticals Inc.  Plunges 5.53% on April 04 Equities.com - Apr 4, 2017 Tetraphase Pharmaceuticals Inc.  had a rough trading day for Tuesday April 04 as shares tumbled 5.53%, or a loss of $-0.51 per share, to close at $8.71.Analysts Near-Term outlook: Tetraphase Pharmaceuticals, Inc. , Fulton ... - The USA Commerce'
p6
aS"Today's Research Reports on Biotech Stocks to Watch: Inotek Pharmaceuticals ... Yahoo Finance - Mar 13, 2017 NEW YORK, NY / ACCESSWIRE / March 13, 2017 / For biotech pharmaceutical companies, the FDA approval process is beyond critical for the financial health of the company and its stakeholders. Getting fast tracked by the FDA is a significant boost. Most of&nbsp;..."
p7
aS'Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-6076, a ... GlobeNewswire  - Aug 1, 2016 WATERTOWN, Mass., Aug. 01, 2016  -- Tetraphase Pharmaceuticals, Inc.  today announced the initiation of patient dosing in a phase 1 clinical trial for intravenous  TP-6076, a novel antibiotic candidate being&nbsp;...'
p8
aS'Price Alert: Tetraphase Pharmaceuticals Inc  Stock Nears ... CML News - Apr 15, 2017 Price Alert: Tetraphase Pharmaceuticals Inc  has now crossed into technical strength -- watch the technical oscillators for momentum gaps.'
p9
aS'Tetraphase Pharmaceuticals to Present at 2016 JMP Securities Life Sciences ... GlobeNewswire  - Jun 15, 2016 WATERTOWN, Mass., June 15, 2016  -- Tetraphase Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant  infections, today&nbsp;...'
p10
a.